Atopic Eczema with detail on how to apply wet wraps

Size: px
Start display at page:

Download "Atopic Eczema with detail on how to apply wet wraps"

Transcription

1 Atopic Eczema with detail on how to apply wet wraps Dr Carol Hlela Consultant Dermatologist Head of Unit, Department of Dermatology, Paediatrics Red Cross Children s Hospital, UCT

2 Red Cross War Memorial Children s Hospital

3 The many FACIES of Atopic Eczema

4 Very dry skin-may be an early manifestation of AE

5 Prophylactic Moisturisation Full body application of moisturisers for 6-8 months beginning in the first month of life for high risk infants showed a cumulative reduced incidence of AD J Allergy Clin Immunology.2014 Oct; (134(4): J Allergy Clin Immunology.2014 Oct; (134(4): e6.

6 The many FACIES of Atopic Eczema

7 The many FACIES of Atopic Eczema

8 Infant phase(birth to 2 years) face, scalp, extensors of limbs cheeks, spares perioral and perinasa chin, cheilitis spares nappy area

9 AE distribution evolve over months/years

10 You can objectively confirm AE, using the UK working party criteria

11 You can objectively confirm AE, by searching for Signs (stigmata) of cutaneous atopy

12 The many FACIES of Atopic Eczema

13 The many FACIES of Atopic Eczema

14

15 Education Soap substitutes Optimal topical care (emollients) Specific therapy: Management principles AE (to control the disease) corticosteroids / calcinuerin inhibitors Antihistamines systemic therapy e.g. Azathioprine, Methotrexate ultraviolet light therapy

16 Education in AE Work with patients and parents as a team. Education Written instructions Address steroid phobia

17 Avoiding triggers Soaps ( use emollient wash products) Bubble baths Woolen or rough fabric clothes Fragrances Aggressive antiseptics Shampoos with high content sodium lauryl sulphate?cats Sweat (use wet wraps) Dry climates (increase frequency of moisturizing)

18 Atopic Eczema - a chronic skin disease

19

20 Bathing Practice Bath/ shower once a day in warm (not hot) water Avoid soap Use a soap substitute such as aqueous cream bath oils, liquid paraffin Pat dry

21 Basis of management Moisturisers Should be used continuously even when skin is clear?ideal moisturiser: unperfumed, low ph Guided by patients needs and preferences Emulsifying ointment or cetomacrogol or Vaseline Avoid aqueous cream Applied frequently, after bathing and swimming Within 3 min of a luke warm bath or shower Prescribed in large quantities (250g/wk)

22 Topical corticosteroids Mainstay of pharmacological treatment vast majority respond very rapidly to adequate topical steroid treatment But: -need adequate quantities -need correct potency (mid to high potent) -steroid phobia -applied for maximum 2 weeks, before side effects occur

23

24 Prescribing topical steroids -Vehicle: Ointment dry eczema Lotion- wet eczema or scalp Creams wet eczema or eczema in folds Gel - scalp and wet eczema

25 Quantity Do not under-prescribe!

26 Prescribing topical steroids Once daily as effective as twice daily Acute flare: Intermittent use 7-14 days with emollient only steroid holidays Short bursts may be needed for flares Start potent, wean down Maintenance: Least potent that controls disease weekend therapy

27 Topical calcineurin inhibitors Not cause skin atrophy Pimecrolimus 1% (Elidel) is approved for mild AD, less effective than betamethasone Tacrolimus (0.03%) is superior May be useful for face, periorbital and intertriginous areas

28 Adjuvant therapy-in AE

29 NICE UK GUIDELINES

30 The many FACIES of Atopic Eczema

31 Benefits- Wet wrap therapy Ancient practice - in Babylon and Egypt To cool skin, anti-inflammatory, itch reduction For severe, refractory AD Safe and effective Biggest barrier: it s time consuming

32 Side effects- Wet wrap therapy Increased infectious complications- folliculitis, impetigo, herpes Skin atrophy, striae, easy bruising, hypopigmentation, telangiectasia, steroid acne, steroid rosacea, hirsutism, contact dermatitis Rare: suppression of HPA axis, growth retardation, cataracts, glaucoma, tachyphylaxis, Cushing's

33 Conclusions there are many facies of atopic eczema intervene appropriately depending on the stage of AE the vast majority will respond to optimal topical care Emollients Topical corticosteroids/tcis moderate-severe AE require WWT -acute intervention WWT should be considered as a treatment option ahead of systemic immunosuppressives

Children s Hospital Of Wisconsin

Children s Hospital Of Wisconsin Children s Hospital Of Wisconsin Co-Management Guidelines To support collaborative care, we have developed guidelines for our community providers to utilize when referring to, and managing patients with,

More information

Learning Circle: Jan 26, 2011 Childhood Eczema

Learning Circle: Jan 26, 2011 Childhood Eczema Learning Circle: Jan 26, 2011 Childhood Eczema Wingfield Rehmus, MD MPH BC Children s Hospital Clinical Assistant Professor, UBC Department of Paediatrics Associate Member, UBC Department of Dermatology

More information

RELEVANT DISCLOSURES ATOPIC DERMATITIS / ECZEMA MANAGING ECZEMA IN INFANTS AND CHILDREN

RELEVANT DISCLOSURES ATOPIC DERMATITIS / ECZEMA MANAGING ECZEMA IN INFANTS AND CHILDREN RELEVANT DISCLOSURES MANAGING ECZEMA IN INFANTS AND CHILDREN Advisory board member - MEDA (Elidel), Speaking honoraria Bayer (Advantan) Advisory board, consultant, speaker: Pfizer, Abbvie, Janssen, Elli

More information

Texas Children's Hospital Dermatology Service PCP Referral Guidelines- Atopic Dermatitis (AD)

Texas Children's Hospital Dermatology Service PCP Referral Guidelines- Atopic Dermatitis (AD) Diagnosis: ATOPIC DERMATITIS (AD) Texas Children's Hospital Dermatology Service PCP Referral Guidelines- Atopic Dermatitis (AD) PATIENT ADVICE: Unfortunately, there is no cure for atopic dermatitis, so

More information

15 minute eczema consultation

15 minute eczema consultation THERAPY WORKSHOP 15 minute eczema consultation History Current treatments Examination Treatment Plan Written action plan Soap substitute/bath oil Antiseptic baths Emollients Topical steroids Other treatments

More information

過敏病科中心. Allergy Centre. Eczema. Allergy Centre 過敏病科中心. Allergy Centre. For enquiries and appointments, please contact us at:

過敏病科中心. Allergy Centre. Eczema. Allergy Centre 過敏病科中心. Allergy Centre. For enquiries and appointments, please contact us at: Allergy Centre 過敏病科中心 Eczema For enquiries and appointments, please contact us at: Allergy Centre 9/F, Li Shu Pui Block Hong Kong Sanatorium & Hospital 2 Village Road, Happy Valley, Hong Kong Tel: 2835

More information

Childhood Eczema Flowchart

Childhood Eczema Flowchart Childhood Eczema Flowchart EXCLUSIONS -Over 15 years of age -Contact dermatitis -Seborrhoeic Eczema -Mild and Moderate Eczema Childhood Eczema Assess Eczema Severity RED FLAGS -Eczema Herpecitum -Severe

More information

New Medicine Report. Pimecrolimus. RED- Hospital only Date of Last Revision 6 th March 2003

New Medicine Report. Pimecrolimus. RED- Hospital only Date of Last Revision 6 th March 2003 New Medicine Report Document Status Pimecrolimus Reviewed by Suffolk D&T RED- Hospital only Date of Last Revision 6 th March 2003 Approved Name Pimecrolimus Trade Name Elidel Manufacturer Novartis Legal

More information

PRODUCT INFORMATION ELEUPHRAT CREAM, OINTMENT AND LOTION. Betamethasone dipropionate equivalent to betamethasone 0.5 mg/g (0.

PRODUCT INFORMATION ELEUPHRAT CREAM, OINTMENT AND LOTION. Betamethasone dipropionate equivalent to betamethasone 0.5 mg/g (0. PRODUCT INFORMATION ELEUPHRAT CREAM, OINTMENT AND LOTION NAME OF THE MEDICINE Betamethasone dipropionate equivalent to betamethasone 0.5 mg/g (0.05% w/w) Chemical Structure: Betamethasone dipropionate

More information

TCIs are only available on prescription and are usually started by a dermatology specialist.

TCIs are only available on prescription and are usually started by a dermatology specialist. (TCIs) What are topical calcineurin inhibitors? Topical calcineurin inhibitors are treatments that alter the immune system and have been developed for controlling eczema. There are two types available:

More information

Teledermatology Paediatric eczema. Dr Carolyn Charman Consultant Dermatologist Royal Devon and Exeter Hospital

Teledermatology Paediatric eczema. Dr Carolyn Charman Consultant Dermatologist Royal Devon and Exeter Hospital Teledermatology Paediatric eczema Dr Carolyn Charman Consultant Dermatologist Royal Devon and Exeter Hospital NHS e-referral teledermatology Rapid access to diagnosis / management advice from local integrated

More information

DATA SHEET. Betamethasone dipropionate equivalent to betamethasone 0.5mg/g (0.05% w/w).

DATA SHEET. Betamethasone dipropionate equivalent to betamethasone 0.5mg/g (0.05% w/w). DATA SHEET 1. DIPROSONE DIPROSONE (0.05% w/w) cream DIPROSONE (0.05% w/w) ointment 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Betamethasone dipropionate equivalent to betamethasone 0.5mg/g (0.05% w/w).

More information

Steroid use in managing your child s Atopic Eczema

Steroid use in managing your child s Atopic Eczema Steroid use in managing your child s Atopic Eczema Clinical Nurse Specialist for Paediatric Dermatology (01284) 713575 Step up step down approach: Addressograph Severe Call your General Practitioner (GP)

More information

Diagnosis and Management of Common and Infective Skin Diseases in Children at primary care level

Diagnosis and Management of Common and Infective Skin Diseases in Children at primary care level Diagnosis and Management of Common and Infective Skin Diseases in Children at primary care level Dr Ng Su Yuen Paediatrician and Paediatric Dermatologist Hospital Pulau Pinang Outline Common inflammatory

More information

What s Topical About Topicals?

What s Topical About Topicals? What s Topical About Topicals? Megha M. Tollefson, MD Associate Professor of Dermatology and Pediatrics July 29, 2017 2015 MFMER 3513105-1 Disclosures None 2015 MFMER 3513105-2 Outline Topical steroids

More information

ECZEMA. Introduction. Differential diagnoses. Starship Children s Health Clinical Guideline

ECZEMA. Introduction. Differential diagnoses. Starship Children s Health Clinical Guideline Introduction Differential Diagnoses Indications for Admission Inpatient Treatment Flow Chart for Inpatient Care Outpatient Treatment References See also Auckland Regional Clinical Pathways for Eczema (with

More information

Topical Immunomodulator Step Therapy Program

Topical Immunomodulator Step Therapy Program Topical Immunomodulator Step Therapy Program Policy Number: 5.01.557 Last Review: 8/2017 Origination: 7/2013 Next Review: 8/2018 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) BCBSKC will provide

More information

Assessing the Current Treatment of Atopic Dermatitis: Unmet Needs

Assessing the Current Treatment of Atopic Dermatitis: Unmet Needs Transcript Details This is a transcript of a continuing medical education (CME) activity accessible on the ReachMD network. Additional media formats for the activity and full activity details (including

More information

Management of eczema in infants and children Assoc Prof David Orchard Director, Department of Dermatology Royal Children s Hospital

Management of eczema in infants and children Assoc Prof David Orchard Director, Department of Dermatology Royal Children s Hospital Atopic dermatitis definition Management of eczema in infants and children Assoc Prof David Orchard Director, Department of Dermatology Royal Children s Hospital Atopic dermatitis is long lasting (chronic)

More information

ATOPIC ECZEMA. What are the aims of this leaflet?

ATOPIC ECZEMA. What are the aims of this leaflet? ATOPIC ECZEMA What are the aims of this leaflet? This leaflet has been written to help you understand more about atopic eczema. It tells you what it is, what causes it, what can be done about it, and where

More information

What is atopic dermatitis?

What is atopic dermatitis? What is atopic dermatitis? Complex inflammatory skin disorder intense pruritus cutaneous hyperreactivity immune dysregulation Chronic with exacerbations and remissions Affects all ages, but more common

More information

Dermatitis (inflammatory skin condition) Nonallergic. dermatitis. Non-atopic eczema (non- IgE mediated)

Dermatitis (inflammatory skin condition) Nonallergic. dermatitis. Non-atopic eczema (non- IgE mediated) Atopic Eczema Dermatitis (inflammatory skin condition) Allergic dermatitis -eczema Nonallergic dermatitis Atopic eczema (IgE mediated) Non-atopic eczema (non- IgE mediated) Pathophysiology of Eczema Allergy

More information

Constitutional eczema

Constitutional eczema Patient information Constitutional eczema What is constitutional eczema? Constitutional eczema, also called atopic eczema, is a form of eczema that mainly occurs in childhood. Eczema usually starts before

More information

LRI Children s Hospital

LRI Children s Hospital Atopic Eczema Care LRI Children s Hospital Staff relevant to: Clinical staff working within the UHL Children s Hospital. Team approval date: May 2017 Version: V 4 Revision due: May 2020 Written by: K.

More information

PRESCRIBING INFORMATION. ratio-topisone. Betamethasone dipropionate USP. 0.5 mg Cream, Ointment and Lotion. Topical corticosteroid

PRESCRIBING INFORMATION. ratio-topisone. Betamethasone dipropionate USP. 0.5 mg Cream, Ointment and Lotion. Topical corticosteroid PRESCRIBING INFORMATION ratio-topisone Betamethasone dipropionate USP 0.5 mg Cream, Ointment and Lotion Topical corticosteroid Teva Canada Limited Date of Revision 30 Novopharm Court January 21, 2013 Toronto,

More information

Professor Rohan Ameratunga Clinical Immunologist and Allergist Auckland

Professor Rohan Ameratunga Clinical Immunologist and Allergist Auckland Professor Rohan Ameratunga Clinical Immunologist and Allergist Auckland 16:30-17:25 WS #170: Eczema Management 17:35-18:30 WS #182: Eczema Management (Repeated) Managing ECZEMA A/Prof Rohan Ameratunga

More information

DIPROSONE OV Cream and Ointment do not contain preservatives, parabens or lanolin.

DIPROSONE OV Cream and Ointment do not contain preservatives, parabens or lanolin. PRODUCT INFORMATION DIPROSONE OV (OPTIMISED VEHICLE) CREAM AND OINTMENT NAME OF THE MEDICINE DIPROSONE OV Cream and Ointment (Betamethasone dipropionate) Chemistry Abstracts Service (CAS) registry number:

More information

TOPCORT Cream/Ointment (Mometasone furoate 0.1%)

TOPCORT Cream/Ointment (Mometasone furoate 0.1%) Published on: 10 Jul 2014 TOPCORT Cream/Ointment (Mometasone furoate 0.1%) Composition TOPCORT Cream Mometasone Furoate, IP... 0.1% w/w In a cream base... q.s. TOPCORT Ointment Mometasone Furoate, IP...

More information

SUMMARY OF PRODUCT CHARACTERISTICS. Excipient with known effect Cetyl alcohol For the full list of excipients, see section 6.1.

SUMMARY OF PRODUCT CHARACTERISTICS. Excipient with known effect Cetyl alcohol For the full list of excipients, see section 6.1. SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Haelan Ointment Fludroxycortide 0.0125% w/w Ointment 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Fludroxycortide 0.0125% w/w. Excipient

More information

The skin is the largest organ of the human body. Functions: protection sensation maintain temperature vitamin synthesis

The skin is the largest organ of the human body. Functions: protection sensation maintain temperature vitamin synthesis Dermatology The skin is the largest organ of the human body. Functions: protection sensation maintain temperature vitamin synthesis The image to the left shows an image of skin cells and the proteins which

More information

What you need to know about ECZEMA

What you need to know about ECZEMA What you need to know about ECZEMA The Irish Skin Foundation is a national charity with a mission to improve quality of life for people with skin conditions, promote skin health and the prevention of skin

More information

The Itch That Rashes. Sarah D. Cipriano, MD, MPH, MS Resident, Dermatology University of Utah

The Itch That Rashes. Sarah D. Cipriano, MD, MPH, MS Resident, Dermatology University of Utah The Itch That Rashes Sarah D. Cipriano, MD, MPH, MS Resident, Dermatology University of Utah 1 Conflict of Interest No conflict of interest Will discuss off label use of medications 2 3 Most likely diagnosis?

More information

What you need to know about ECZEMA

What you need to know about ECZEMA What you need to know about ECZEMA The Irish Skin Foundation is a national charity with a mission to improve quality of life for people with skin conditions, promote skin health and the prevention of skin

More information

Medication Policy Manual. Topic: Dupixent, dupilumab Date of Origin: March 10, Committee Approval: March 10, 2017 Next Review Date: May 2018

Medication Policy Manual. Topic: Dupixent, dupilumab Date of Origin: March 10, Committee Approval: March 10, 2017 Next Review Date: May 2018 Independent licensees of the Blue Cross and Blue Shield Association Medication Policy Manual Policy No: dru493 Topic: Dupixent, dupilumab Date of Origin: March 10, 2017 Committee Approval: March 10, 2017

More information

Paediatric Eczema. Dr Manjeet Joshi Consultant Dermatologist 16 th May 2012

Paediatric Eczema. Dr Manjeet Joshi Consultant Dermatologist 16 th May 2012 Paediatric Eczema Dr Manjeet Joshi Consultant Dermatologist 16 th May 2012 Classification of the principal forms of eczema EXOGENOUS ENDOGENOUS Irritant Allergic contact Photoallergic contact Eczematous

More information

Dr David Orchard MBBS FACD

Dr David Orchard MBBS FACD Eczema Dr David Orchard MBBS FACD What is eczema? Eczema is a particular type of inflammatory reaction in the skin. The features include redness, scaling and itch. When it is more severe the skin will

More information

Dermatology Literary Review

Dermatology Literary Review Emollients and ageing skin: optimising effectiveness and safety of Nursing, Vol. 25, No.11, pages 596-598. 6 Article outlines the causes of dryness in ageing skin and concludes that emollients are the

More information

Prescribing Information

Prescribing Information Prescribing Information Pr DERMOVATE Cream (clobetasol propionate cream, USP) Pr DERMOVATE Ointment (clobetasol propionate ointment, USP) Topical corticosteroid TaroPharma Preparation Date: A Division

More information

SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT 2 QUALITATIVE AND QUANTITATIVE COMPOSITION

SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT 2 QUALITATIVE AND QUANTITATIVE COMPOSITION SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Hydrocortisone Cream 1% 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Cream containing 1% micronised hydrocortisone For excipients, see 6.1

More information

An Everyday Guide to Eczema

An Everyday Guide to Eczema An Everyday Guide to Eczema By Dr. Kristel Polder, Board-Certified Dermatologist Developed in Partnership with Who is affected by eczema? 32 million people in the US 1 in 5 children 1 in 12 adults *www.eczema.org

More information

Skin Deep: Or is It? Practical Pearls from a Pediatric Dermatologist

Skin Deep: Or is It? Practical Pearls from a Pediatric Dermatologist Skin Deep: Or is It? Practical Pearls from a Pediatric Dermatologist I have no conflicts of interest 6 yo boy referred for AD. On topical HC and food elimination diet s/p topical triamcinolone to body

More information

Technology appraisal guidance Published: 25 August 2004 nice.org.uk/guidance/ta82

Technology appraisal guidance Published: 25 August 2004 nice.org.uk/guidance/ta82 Tacrolimus and pimecrolimus for atopic eczema Technology appraisal guidance Published: 25 August 2004 nice.org.uk/guidance/ta82 NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).

More information

Clinical guideline Published: 12 December 2007 nice.org.uk/guidance/cg57

Clinical guideline Published: 12 December 2007 nice.org.uk/guidance/cg57 Atopic eczema in under 12s: diagnosis and management Clinical guideline Published: 12 December 2007 nice.org.uk/guidance/cg57 NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).

More information

Understanding. Atopic Dermatitis. National Jewish Health. An educational health series from

Understanding. Atopic Dermatitis. National Jewish Health. An educational health series from Understanding Atopic Dermatitis An educational health series from National Jewish Health If you would like further information about National Jewish Health, please write to: National Jewish Health 1400

More information

50 microgram/g Calcipotriol and 500 microgram/g betamethasone (as dipropionate).

50 microgram/g Calcipotriol and 500 microgram/g betamethasone (as dipropionate). DUPISOR Composition Gel 50 microgram/g Calcipotriol and 500 microgram/g betamethasone (as dipropionate). Action Calcipotriol is a non-steroidal antipsoriatic agent, derived from vitamin D. Calcipotriol

More information

What are the symptoms of a vulval skin condition?

What are the symptoms of a vulval skin condition? Information for you Published in December 2013 Skin conditions of the vulva About this information This information is for you if you want to know about skin conditions affecting the vulva. If you are

More information

Clinical guideline Published: 12 December 2007 nice.org.uk/guidance/cg57

Clinical guideline Published: 12 December 2007 nice.org.uk/guidance/cg57 Atopic eczema in under 12s: diagnosis and management Clinical guideline Published: 12 December 2007 nice.org.uk/guidance/cg57 NICE 2007. All rights reserved. Contents Introduction... 4 Child-centred care...

More information

UPDATES IN ATOPIC DERMATITIS

UPDATES IN ATOPIC DERMATITIS UPDATES IN ATOPIC DERMATITIS Amanda Hess, MMS, PA-C President-Elect, AAPA-AAI Arizona Asthma and Allergy Institute, Scottsdale, AZ LEARNING OBJECTIVES Discuss epidemiology, risk factors, and causes of

More information

Fluocinolone Acetonide 0.01% Topical Oil (Scalp Oil)

Fluocinolone Acetonide 0.01% Topical Oil (Scalp Oil) Fluocinolone Acetonide 0.01% Topical Oil (Scalp Oil) For Topical Use Only- Not for Oral, Ophthalmic, or Intravaginal Use DESCRIPTION Fluocinolone Acetonide 0.01% Topical Oil contains fluocinolone acetonide

More information

ATOPIC DERMATITIS: A BLUEPRINT FOR SUCCESS. Sierra Wolter MD, FAAD Pediatric Dermatology University of Arizona, College of Medicine

ATOPIC DERMATITIS: A BLUEPRINT FOR SUCCESS. Sierra Wolter MD, FAAD Pediatric Dermatology University of Arizona, College of Medicine ATOPIC DERMATITIS: A BLUEPRINT FOR SUCCESS Sierra Wolter MD, FAAD Pediatric Dermatology University of Arizona, College of Medicine THE PLAN Is it atopic dermatitis? What is atopic dermatitis? Guidelines

More information

Rashes Not To Be Missed In Children

Rashes Not To Be Missed In Children May 2016 Rashes Not To Be Missed In Children Dr Chan Yuin Chew Dermatologist Dermatology Associates Gleneagles Medical Centre Scope of presentation Focus on rashes May lead to significant morbidity if

More information

Managing and Minimizing Flare-ups in Atopic Dermatitis

Managing and Minimizing Flare-ups in Atopic Dermatitis Managing and Minimizing Flare-ups in Atopic Dermatitis Importance of the skin barrier & how commonly used drugs are impacting it Dr. Benjamin Barankin, MD FRCPC Medical Director & Founder of Toronto Dermatology

More information

A Child with Eczema: A Parent s Guide

A Child with Eczema: A Parent s Guide A Child with Eczema: A Parent s Guide What is eczema? Originally the term eczema was used to describe any itchy rash that blistered; now eczema describes skin which is red (inflamed) and intensely itchy.

More information

Managing Atopic Derma00s: Itching the Night Away. Karol Timmons RN, MS, CPNP Boston Children s Hospital Atopic Derma00s Center

Managing Atopic Derma00s: Itching the Night Away. Karol Timmons RN, MS, CPNP Boston Children s Hospital Atopic Derma00s Center Managing Atopic Derma00s: Itching the Night Away Karol Timmons RN, MS, CPNP Boston Children s Hospital Atopic Derma00s Center Learning Objec-ves Describe common treatments for atopic derma00s including:

More information

8-year surveillance 2016 Atopic eczema in under 12s (2007) NICE guideline CG57

8-year surveillance 2016 Atopic eczema in under 12s (2007) NICE guideline CG57 8-year 2016 Atopic eczema in under 12s (2007) NICE guideline CG57 Appendix A: decision matrix year Diagnosis 57 01 What criteria should be used to diagnose atopic eczema in children and how do they vary

More information

Eczema. Most kids get itchy rashes at one time or another. But eczema can be a nuisance that may prompt scratching that makes the problem worse.

Eczema. Most kids get itchy rashes at one time or another. But eczema can be a nuisance that may prompt scratching that makes the problem worse. KidsHealth.org The most-visited site devoted to children's health and development Eczema Most kids get itchy rashes at one time or another. But eczema can be a nuisance that may prompt scratching that

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. Flutarzole 0,05% w/w cream, Fluticasone propionate

PACKAGE LEAFLET: INFORMATION FOR THE USER. Flutarzole 0,05% w/w cream, Fluticasone propionate PACKAGE LEAFLET: INFORMATION FOR THE USER Flutarzole 0,05% w/w cream, Fluticasone propionate 1. IDENTIFICATION OF THE MEDICINAL PRODUCT 1.1. Trade name Flutarzole 1.2. Composition Active substance: Fluticasone

More information

Recommended management of eczema in older patients

Recommended management of eczema in older patients Recommended management of eczema in older patients Victoria Sherman MA, MRCP and Daniel Creamer BSc, MD, FRCP Our series Prescribing in older people gives practical advice for successful management of

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Hydrocortisone Cream 1 % Skin Calm Cream 1 % 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Cream containing 1% micronised hydrocortisone

More information

SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT

SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Haelan Tape Fludroxycortide 4 micrograms per square centimetre Tape 2. QUALITATIVE AND QUANTITATIVE COMPOSITION The tape is impregnated

More information

Prescribing Information. Taro-Clobetasol. Taro-Clobetasol

Prescribing Information. Taro-Clobetasol. Taro-Clobetasol Prescribing Information Pr Taro-Clobetasol Clobetasol Propionate Cream USP, 0.05% w/w Pr Taro-Clobetasol Clobetasol Propionate Ointment USP, 0.05% w/w Therapeutic Classification Topical corticosteroid

More information

For topical use only. Not for oral, ophthalmic, or intravaginal use.

For topical use only. Not for oral, ophthalmic, or intravaginal use. DESOXIMETASONE Ointment USP, 0.25% For topical use only. Not for oral, ophthalmic, or intravaginal use. Rx only DESCRIPTION Desoximetasone ointment USP, 0.25% contains the active synthetic corticosteroid

More information

ECZEMA. Introduction. Differential diagnoses. Starship Children s Health Clinical Guideline

ECZEMA. Introduction. Differential diagnoses. Starship Children s Health Clinical Guideline Introduction Differential Diagnoses Indications for Admission Inpatient Treatment Flow Chart for Inpatient Care Outpatient Treatment References Introduction Eczema (also called atopic dermatitis) is characterised

More information

Pharmacologic Treatment of Atopic Dermatitis

Pharmacologic Treatment of Atopic Dermatitis J KMA Pharmacotherapeutics Pharmacologic Treatment of Atopic Dermatitis Chun Wook Park, MD Department of Dermatology, Hallym University College of Medicine E mail : dermap@paran.com J Korean Med Assoc

More information

Contact Allergy Testing (Patch Testing) Information for parents and carers of children up to 12 years of age

Contact Allergy Testing (Patch Testing) Information for parents and carers of children up to 12 years of age Contact Allergy Testing (Patch Testing) Information for parents and carers of children up to 12 years of age Dermatology Department The aim of this leaflet is to give you information about contact allergy

More information

NEW ZEALAND DATA SHEET 1 LOCOID 2 QUALITATIVE AND QUANTITATIVE COMPOSTION 3 PHARMACEUTICAL FORM 4 CLINICAL PARTICULARS

NEW ZEALAND DATA SHEET 1 LOCOID 2 QUALITATIVE AND QUANTITATIVE COMPOSTION 3 PHARMACEUTICAL FORM 4 CLINICAL PARTICULARS NEW ZEALAND DATA SHEET 1 LOCOID Lipocream Ointment Topical Emulsion (Locoid Crelo ) Scalp Lotion hydrocortisone butyrate 2 QUALITATIVE AND QUANTITATIVE COMPOSTION Each formulation contains active ingredient

More information

Time to Learn. 6 th March 2018 Dr. Shirin Chakera GPwSI Integrated Dermatology Service

Time to Learn. 6 th March 2018 Dr. Shirin Chakera GPwSI Integrated Dermatology Service Time to Learn 6 th March 2018 Dr. Shirin Chakera GPwSI Integrated Dermatology Service The Red Face Rosacea Acne Seborrhoeic eczema eczema Psoriasis Slapped cheek syndrome Fungal infection Erysipelas...

More information

Atopic Dermatitis: Therapeutic Challenges

Atopic Dermatitis: Therapeutic Challenges Atopic Dermatitis: Therapeutic Challenges PDA August 14, 2009 Jon Hanifin OHSU, Portland Dominant Concepts in Atopic Dermatitis Allergy / Immunology Era: 1915-2006 The Epidermal Era: 2006---- Barrier dysfunction

More information

BETNOVATE Betamethasone 17-valerate

BETNOVATE Betamethasone 17-valerate BETNOVATE Betamethasone 17-valerate Betamethasone valerate is referred to as Betnovate throughout this information. PRESENTATION BETNOVATE Cream (non-greasy base) 0.1% betamethasone as 17-valerate in a

More information

Dermatology Literary Review

Dermatology Literary Review Literary Review 2015 to 2015 Working together to manage common skin conditions British Nursing, Vol. 24, No. 21, pages 1052-1053. 26 November Article discusses the incidence and prevalence of skin conditions,

More information

Thursday, 21 October :53 - Last Updated Thursday, 11 November :27

Thursday, 21 October :53 - Last Updated Thursday, 11 November :27 1 / 15 2 / 15 3 / 15 4 / 15 Pityriasis Alba Background Pityriasis alba is a nonspecific dermatitis of unknown etiology that causes erythematous scaly patches. These resolve and leave areas of hypopigmentation

More information

Cordran Cream and Cordran Ointment Flurandrenolide, USP

Cordran Cream and Cordran Ointment Flurandrenolide, USP Cordran Cream and Cordran Ointment Flurandrenolide, USP DESCRIPTION Cordran (flurandrenolide, USP) is a potent corticosteroid intended for topical use. Flurandrenolide occurs as white to off-white, fluffy,

More information

COMMON SKIN CONDITIONS IN PRIMARY CARE. Ibrahim M. Zayneh, MD Dermatology Private Practice, Portsmouth, Ohio

COMMON SKIN CONDITIONS IN PRIMARY CARE. Ibrahim M. Zayneh, MD Dermatology Private Practice, Portsmouth, Ohio COMMON SKIN CONDITIONS IN PRIMARY CARE Ibrahim M. Zayneh, MD Dermatology Private Practice, Portsmouth, Ohio DISCLOSURE The Speaker and members of the planning committee do not have a conflict of interest

More information

Clinico Pathological Test SCPA605-Essential Pathology

Clinico Pathological Test SCPA605-Essential Pathology Clinico Pathological Test SCPA605-Essential Pathology Somphong Narkpinit, M.D. Department of Pathogbiology, Faculty of Science, Mahidol University e-mail : somphong.nar@mahidol.ac.th Pathogenesis of allergic

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Ovixan 1 mg/g cream 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One gram cream contains 1 mg mometasone furoate Excipients with known

More information

ATOPIC DERMATITIS IN CHILDREN. Simple choice questions

ATOPIC DERMATITIS IN CHILDREN. Simple choice questions ATOPIC DERMATITIS IN CHILDREN Simple choice questions 1. Which is the principal cause of atopic dermatitisdevelopment in little age children? A. Psychoemotional factors. B. Habitual antigens. C. Food allergy.

More information

Treating dermatomyositis

Treating dermatomyositis Treating dermatomyositis David Fiorentino, MD, PhD Stanford University School of Medicine Department of Dermatology Department of Medicine (Rheumatology) September 25, 2010 DM affects many organs Approaching

More information

Volume 2; Number 2 February 2008

Volume 2; Number 2 February 2008 Volume 2; Number 2 February 2008 CONTENTS Page 2 Page 3 Page 3 Page 4 Page 6 New Drug Assessment: Rufinamide (Inovelon) New Drug Assessment: Zoledronic acid infusion (Aclasta) New Drug Assessment: Mesalazine

More information

For the use only of Registered Medical Practitioners or a Hospital or a Laboratory BETNOVATE - S

For the use only of Registered Medical Practitioners or a Hospital or a Laboratory BETNOVATE - S For the use only of Registered Medical Practitioners or a Hospital or a Laboratory BETNOVATE - S Betamethasone Valerate and Salicylic Acid Skin Ointment QUALITATIVE AND QUANTITATIVE COMPOSITION BETNOVATE

More information

CENTENE PHARMACY AND THERAPEUTICS NEW DRUG REVIEW 3Q17 July August

CENTENE PHARMACY AND THERAPEUTICS NEW DRUG REVIEW 3Q17 July August BRAND NAME Dupixent GENERIC NAME dupilumab MANUFACTURER Regeneron DATE OF APPROVAL March 28, 2017 PRODUCT LAUNCH DATE First week of April 2017 REVIEW TYPE Review type 1 (RT1): New Drug Review Full review

More information

Contact Dermatitis In Atopic Patients

Contact Dermatitis In Atopic Patients Contact Dermatitis In Atopic Patients Jenny Murase, MD Palo Alto Foundation Medical Group Director of Patch Testing University of California, San Francisco Associate Clinical Professor Disclosures Consultant

More information

IMMUNODEFICIENCIES PRIMARY ALLERGIES PRIMARY IMMUNODEFICIENCIES AND ALLERGIES

IMMUNODEFICIENCIES PRIMARY ALLERGIES PRIMARY IMMUNODEFICIENCIES AND ALLERGIES PRIMARY IMMUNODEFICIENCIES ALLERGIES PRIMARY IMMUNODEFICIENCIES AND ALLERGIES 1 PRIMARY IMMUNODEFICIENCIES KEY ABBREVIATIONS IgE CID Immunoglobulin E Combined Immunodeficiency IL5 Interleukin 5 IPOPI PID

More information

TRIGGERS & TREATMENT OF ATOPIC DERMATITIS COA#PCIA0809 CE Activity provided by PCI Journal

TRIGGERS & TREATMENT OF ATOPIC DERMATITIS COA#PCIA0809 CE Activity provided by PCI Journal TRIGGERS & TREATMENT OF ATOPIC DERMATITIS COA#PCIA0809 CE Activity provided by PCI Journal INSTRUCTIONS 1. Read the article. 2. Take the test, record your answers in the test answer section (Section B)

More information

Faculty Information ECZEMA: THE ITCH THAT RASHES 2/13/2015. Disclosures and COI Resolution. Pharmacy Accreditation

Faculty Information ECZEMA: THE ITCH THAT RASHES 2/13/2015. Disclosures and COI Resolution. Pharmacy Accreditation Faculty Information ECZEMA: THE ITCH THAT RASHES A CONTINUING EDUCATION WEBINAR Speaker Celia Lu, Pharm.D, BCACP Assistant Clinical Professor St. John s University College of Pharmacy & Health Sciences

More information

HYDROCORTISONE OINTMENT USP,

HYDROCORTISONE OINTMENT USP, HYDROCORTISONE- hydrocortisone ointment E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. ---------- HYDROCORTISONE OINTMENT USP, 1% Rx only For External Us e Only Not For Ophthalmic Us e DESCRIPTION:

More information

Psoriasis: Causes, Symptoms, And Treatment

Psoriasis: Causes, Symptoms, And Treatment Psoriasis: Causes, Symptoms, And Treatment We all know that a healthy immune system is good. But, do you know that an overactive immune system can cause certain conditions like Psoriasis? Read on to find

More information

PDP SELF-TEST QUESTIONNAIRE ECZEMAS. Number 1 THE CORE TUTORIALS IN DERMATOLOGY FOR PRIMARY CARE UPDATED PDP SELF-TEST QUESTIONNAIRE 2010

PDP SELF-TEST QUESTIONNAIRE ECZEMAS. Number 1 THE CORE TUTORIALS IN DERMATOLOGY FOR PRIMARY CARE UPDATED PDP SELF-TEST QUESTIONNAIRE 2010 Number 1 CORE TUTORIALS IN DERMATOLOGY FOR PRIMARY CARE PDP SELF-TEST QUESTIONNAIRE OLD FAITHFUL GEYSER OF NAPA VALLEY, CALIFORNIA THE ECZEMAS UPDATED PDP SELF-TEST QUESTIONNAIRE 2010 From Greek: Eczema

More information

Dermatology Round Up

Dermatology Round Up Dermatology Round Up Journal of Family Health Care Live Conference 25 March 2014 Julie Van Onselen Independent Dermatology Nurse, Oxford And Rachael Fagg, Mother Introduction 10.00 10.30hrs: Julie Van

More information

PUBLIC SUMMARY OF RISK MANAGEMENT PLAN (RMP) Elidel 10mg/g cream DATE: , VERSION 12.0

PUBLIC SUMMARY OF RISK MANAGEMENT PLAN (RMP) Elidel 10mg/g cream DATE: , VERSION 12.0 PUBLIC SUMMARY OF RISK MANAGEMENT PLAN (RMP) Elidel 10mg/g cream DATE: 23.11.2016, VERSION 12.0 VI.2 VI.2.1 Elements for a Public Summary Overview of disease epidemiology Eczema mainly affects children

More information

Vulval dermatoses. Dr Fiona Lewis, Consultant Dermatologist St John s Institute of Dermatology, London & Heatherwood & Wexham Park Hospital, Slough

Vulval dermatoses. Dr Fiona Lewis, Consultant Dermatologist St John s Institute of Dermatology, London & Heatherwood & Wexham Park Hospital, Slough Vulval dermatoses Dr Fiona Lewis, Consultant Dermatologist St John s Institute of Dermatology, London & Heatherwood & Wexham Park Hospital, Slough Pigmentation Vulvodynia Ulcers Genetic Pruritus VULVAL

More information

English for Nurses: Eczema Vocabulary allergy allergies be allergic to a bath have a bath to bathe citrus fruits common cool dairy products eczema

English for Nurses: Eczema Vocabulary allergy allergies be allergic to a bath have a bath to bathe citrus fruits common cool dairy products eczema English for Nurses: Eczema Vocabulary allergy allergies be allergic to a bath have a bath to bathe citrus fruits common cool dairy products eczema elbows fingernail a link to link to something make something

More information

NOVASONE CREAM, OINTMENT AND LOTION PRODUCT INFORMATION

NOVASONE CREAM, OINTMENT AND LOTION PRODUCT INFORMATION NAME OF THE MEDICINE Mometasone furoate 0.1% (1 mg/g) Chemical structure: NOVASONE CREAM, OINTMENT AND LOTION PRODUCT INFORMATION Mometasone furoate is 9,21-dichloro-11ß,17-dihydroxy-16 -methylpregna-1,4-diene-

More information

Biologic Therapies for Atopic Dermatitis and Beyond

Biologic Therapies for Atopic Dermatitis and Beyond Biologic Therapies for Atopic Dermatitis and Beyond Jonathan Corren, M.D. Departments of Medicine and Pediatrics, David Geffen School of Medicine at UCLA Disclosures Genentech - research Medimmune/AZ -

More information

NEW ZEALAND DATA SHEET

NEW ZEALAND DATA SHEET EUMOVATE Cream NEW ZEALAND DATA SHEET Name of each active ingredient Clobetasone 17-Butyrate BP 0.05% w/w Presentations Eumovate Cream is white in appearance and contains 0.05% w/w clobetasone butyrate.

More information

Allergy Medications. Antihistamines. are very safe. Although usually taken as tablets, they may be prescribed as a liquid or syrup for young children

Allergy Medications. Antihistamines. are very safe. Although usually taken as tablets, they may be prescribed as a liquid or syrup for young children The treatments prescribed for allergy control the symptoms and reactions; they do not cure the condition. However, using treatments as prescribed can show a huge change in a patient s health, mood and

More information

Severe Atopic Dermatitis Management Guideline

Severe Atopic Dermatitis Management Guideline Severe Atopic Dermatitis Management Guideline Severe childhood eczema is a mix of acute and chronic management that often involves acute admission. This CPO pathway covers the acute managementto avoidpotential

More information

LUMACIP PLUS Cream (Fluocinolone acetonide 0.01% + Hydroquinone 4% + Tretinoin 0.05%)

LUMACIP PLUS Cream (Fluocinolone acetonide 0.01% + Hydroquinone 4% + Tretinoin 0.05%) Published on: 10 Jul 2014 LUMACIP PLUS Cream (Fluocinolone acetonide 0.01% + Hydroquinone 4% + Tretinoin 0.05%) Composition LUMACIP PLUS Cream Each gram contains: Fluocinolone acetonide IP.. 0.01% w/w

More information

Eucrisa. Eucrisa (crisaborole) Description

Eucrisa. Eucrisa (crisaborole) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.90.25 Subject: Eucrisa Page: 1 of 6 Last Review Date: September 15, 2017 Eucrisa Description Eucrisa

More information

PRIMARY CARE MANAGEMENT OF CHILDHOOD ATOPIC ECZEMA

PRIMARY CARE MANAGEMENT OF CHILDHOOD ATOPIC ECZEMA PRIMARY CARE MANAGEMENT OF CHILDHOOD ATOPIC ECZEMA INTRODUCTION Atopic Eczema is an inflammatory skin disease categorised by an itchy, erythematous, demarcated rash, which has a predilection for the skin

More information

Atopic dermatitis: tacrolimus vs. topical corticosteroid use

Atopic dermatitis: tacrolimus vs. topical corticosteroid use Atopic dermatitis: tacrolimus vs. topical corticosteroid use Langa Y, BPharm Van der Merwe E, BPharm, MSc (Pharmacology) Correspondence to: Elsabe van der Merwe, e-mail: elsabev@medikredit.co.za Keywords:

More information